Additionally, in xenograft models established by subcutaneous implantation of either PC9-parental or EGFR-E804K knock-in cells, the tumor growth and weight of EGFR-E804K knock-in xenografts were significantly reduced (Fig. 5h–j). This evidence concerns the gene EGFR and neoplasm.